Halbert Chanita Hughes, Wenzel Lari, Lerman Caryn, Peshkin Beth N, Narod Steven, Marcus Alfred, Corio Camille, Demarco Tiffani, Bellamy Scarlett
Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104, USA.
Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):875-81.
Although adjunctive educational and psychosocial programs are now being developed for BRCA1 and BRCA2 (BRCA1/2) mutation carriers, limited information is available about whether mutation carriers will want to receive such programs or about the characteristics of individuals who participate. The goals of the present study were to describe rates of completing a psychosocial telephone counseling (PTC) intervention that was offered to female BRCA1/2 mutation carriers and to identify sociodemographic and psychological factors associated with decisions to complete the intervention. Subjects were 66 BRCA1/2 mutation carriers who were randomized to receive a PTC intervention following receipt of genetic test results. Sociodemographic and psychological factors were evaluated before notification of assignment to the PTC intervention. Completion of the intervention was determined from study records. Overall, 75.8% of subjects completed the PTC intervention. Compared to unaffected subjects, those affected with breast and/or ovarian cancer were 76% less likely to complete the intervention [odds ratio (OR) = 0.24, 95% confidence interval (CI) = 0.06, 0.98, P = 0.05]. In addition, subjects with higher levels of cancer-specific distress [OR = 4.74, 95% CI = 1.02, 22.03, P = 0.05] and those with greater perceptions of social support [OR = 5.81, 95% CI = 1.29, 26.16, P = 0.02] were also most likely to complete the intervention. The results of this study suggest that while most BRCA1/2 mutation carriers are likely to complete an adjunctive psycho-educational program, personal history of cancer, cancer-specific distress, and perceptions of social support are likely to influence participation.
尽管目前正在为携带BRCA1和BRCA2(BRCA1/2)基因突变的人群开发辅助教育和心理社会项目,但关于突变携带者是否愿意接受此类项目,或参与项目的个体特征,目前所知信息有限。本研究的目的是描述向女性BRCA1/2突变携带者提供的心理社会电话咨询(PTC)干预的完成率,并确定与完成干预决策相关的社会人口学和心理因素。研究对象为66名BRCA1/2突变携带者,他们在收到基因检测结果后被随机分配接受PTC干预。在通知被分配到PTC干预之前,对社会人口学和心理因素进行了评估。干预的完成情况根据研究记录确定。总体而言,75.8%的研究对象完成了PTC干预。与未受影响的研究对象相比,患有乳腺癌和/或卵巢癌的研究对象完成干预的可能性低76%[优势比(OR)=0.24,95%置信区间(CI)=0.06,0.98,P=0.05]。此外,癌症特异性痛苦程度较高的研究对象[OR=4.74,95%CI=1.02,22.03,P=0.05]和感知到更多社会支持的研究对象[OR=5.81,95%CI=1.29,26.16,P=0.02]也最有可能完成干预。本研究结果表明,虽然大多数BRCA1/2突变携带者可能会完成辅助性心理教育项目,但癌症个人史、癌症特异性痛苦和社会支持感知可能会影响参与情况。